Issue 4, 2020

Radionuclide-labeled gold nanoparticles for nuclei-targeting internal radio-immunity therapy

Abstract

Radionuclide therapy is an important form of tumor internal radiation therapy (IRT), but its curative effect is restricted by the low radiation intensity and poor targeting ability of nuclides, which hampers efficient killing of DNA. Moreover, the limited penetration depth and nonuniform dose distribution of rays result in “blind” regions with residual living cancer cells, which increases the risk of tumor metastasis. Herein, we developed a new strategy to tactfully incorporate IRT with immunotherapy to achieve highly efficient synergistic therapy. Specifically, gold nanoparticles (AuNPs) co-modified with radioactive iodine-131 and the twin arginine translocation (TAT) peptide (131I-AuNPs-TAT) were constructed, in which TAT-guided nuclei targeting provided highly concentrated β-rays to the most radiosensitive DNA. Meanwhile, β electrons dashed on AuNPs with a sudden drop in speed can transform into low-dosage X-ray bremsstrahlung radiation. X-rays have a longer penetration depth than β-rays and are able to induce a strong immune response, thus eliminating the area that is blind to short-range β-rays resulting from the limited dose distribution. This method, named “internal radio-immunity therapy (IRIT)”, is a unique approach that combines IRT with immunotherapy to not only enhance radiotherapeutic efficacy but also broaden the clinical applications of 131I, thereby demonstrating great potential for scientific research and clinical applications.

Graphical abstract: Radionuclide-labeled gold nanoparticles for nuclei-targeting internal radio-immunity therapy

Supplementary files

Article information

Article type
Communication
Submitted
29 Oct 2019
Accepted
13 Dec 2019
First published
13 Dec 2019

Mater. Horiz., 2020,7, 1115-1125

Radionuclide-labeled gold nanoparticles for nuclei-targeting internal radio-immunity therapy

W. Su, C. Chen, T. Wang, X. Li, Y. Liu, H. Wang, S. Zhao, C. Zuo, G. Sun and W. Bu, Mater. Horiz., 2020, 7, 1115 DOI: 10.1039/C9MH01725A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements